Lung Cancer Patients Live Longer with Avastin -Study

WASHINGTON (Reuters) - Lung cancer patients given Genentech Inc.'s drug Avastin along with standard chemotherapy lived longer, the U.S. National Cancer Institute said on Monday, sending the company's shares up 25 percent and raising hopes for treatment of an often fatal cancer.

Continue to Lung Cancer Patients Live Longer with Avastin -Study on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz